Kozák T - Search Results

1

Fayette D, Gahérová Ľ, Móciková H, Marková J, Kozák T, Horáček J. Fayette D, et al. Among authors: kozak t. Klin Onkol. 2017 Spring;30(2):93-99. doi: 10.14735/amko201793. Klin Onkol. 2017. PMID: 28397504 Review. Czech.

2

[Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group].

Móciková H, Marková J, Gahérová Ľ, Král Z, Sýkorová A, Belada D, Procházka V, Martinková L, Papajík T, Kozák T. Móciková H, et al. Among authors: kozak t. Klin Onkol. 2016 Fall;29(5):342-346. doi: 10.14735/amko2016342. Klin Onkol. 2016. PMID: 27739312 Czech.

3

[Treatment of patients with relapsed/refractory Hodgkin lymphoma].

Mociková H, Pytlík R, Raida L, Sýkorová A, Marková J, Král Z, Jindra P, Steinerová K, Válková V, Trnková M, Vacková B, Trnený M, Indrák K, Belada D, Mayer J, Koza V, Kozák T. Mociková H, et al. Among authors: kozak t. Klin Onkol. 2011;24(2):121-5. Klin Onkol. 2011. PMID: 21644367 Czech.

4

[Skeletal involvement in Hodgkin's lymphoma--personal experience].

Feltl D, Marková J, Kozák T. Feltl D, et al. Among authors: kozak t. Vnitr Lek. 2004 Feb;50(2):134-8. Vnitr Lek. 2004. PMID: 15077588 Czech.

5

Prognostic impact of bone involvement in Hodgkin lymphoma.

Feltl D, Markova J, Mocikova H, Dedeckova K, Kozak T. Feltl D, et al. Among authors: kozak t. Neoplasma. 2008;55(2):96-100. Neoplasma. 2008. PMID: 18237246

6

Rituximab-induced coagulopathy.

Novak J, Mocikova H, Pavlicek P, Gaherova L, Kozak T. Novak J, et al. Among authors: kozak t. Leuk Lymphoma. 2012 Nov;53(11):2299-301. doi: 10.3109/10428194.2012.682313. Epub 2012 May 16. Leuk Lymphoma. 2012. PMID: 22480246 Review. No abstract available.

7

[Comparison between conventional imaging methods and positron emission tomography in the treatment of Hodgkin's lymphoma].

Móciková H, Marková J, Bĕlohlávek O, Cáp F, Cermák F, Feltl D, Kozák T. Móciková H, et al. Among authors: kozak t. Cas Lek Cesk. 2004;143(7):476-9; discussion 479-80. Cas Lek Cesk. 2004. PMID: 15373291 Czech.

8

Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) Involvement.

Mociková H, Malikova H, Holesta M, Elturki A, Campr V, Kozak T. Mociková H, et al. Among authors: kozak t. Am J Case Rep. 2020 Mar 14;21:e921657. doi: 10.12659/AJCR.921657. Am J Case Rep. 2020. PMID: 32170052 Free PMC article.

9

Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma.

Mocikova H, Pytlik R, Markova J, Steinerova K, Kral Z, Belada D, Trnkova M, Trneny M, Koza V, Mayer J, Zak P, Kozak T. Mocikova H, et al. Among authors: kozak t. Leuk Lymphoma. 2011 Sep;52(9):1668-74. doi: 10.3109/10428194.2011.573889. Epub 2011 Jun 23. Leuk Lymphoma. 2011. PMID: 21699377

10

Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.

Markova J, Kahraman D, Kobe C, Skopalova M, Mocikova H, Klaskova K, Dedeckova K, Eich HT, Böll B, Dietlein M, Kozak T. Markova J, et al. Among authors: kozak t. Leuk Lymphoma. 2012 Jan;53(1):64-70. doi: 10.3109/10428194.2011.603444. Epub 2011 Aug 24. Leuk Lymphoma. 2012. PMID: 21740300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters